138 related articles for article (PubMed ID: 38468464)
1. GINS1 promotes ZEB1-mediated epithelial-mesenchymal transition and tumor metastasis via β-catenin signaling in hepatocellular carcinoma.
Liang J; Yao N; Deng B; Li J; Jiang Y; Liu T; Hu Y; Cao M; Hong J
J Cell Physiol; 2024 May; 239(5):e31237. PubMed ID: 38468464
[TBL] [Abstract][Full Text] [Related]
2. LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway.
Li SP; Xu HX; Yu Y; He JD; Wang Z; Xu YJ; Wang CY; Zhang HM; Zhang RX; Zhang JJ; Yao Z; Shen ZY
Oncotarget; 2016 Jul; 7(27):42431-42446. PubMed ID: 27285757
[TBL] [Abstract][Full Text] [Related]
3. ARHGEF11 promotes proliferation and epithelial-mesenchymal transition of hepatocellular carcinoma through activation of β-catenin pathway.
Du J; Zhu Z; Xu L; Chen X; Li X; Lan T; Li W; Yuan K; Zeng Y
Aging (Albany NY); 2020 Oct; 12(20):20235-20253. PubMed ID: 33122451
[TBL] [Abstract][Full Text] [Related]
4. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY
Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131
[TBL] [Abstract][Full Text] [Related]
5. TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of β-catenin.
Yuan K; Xie K; Lan T; Xu L; Chen X; Li X; Liao M; Li J; Huang J; Zeng Y; Wu H
Cell Death Differ; 2020 Apr; 27(4):1355-1368. PubMed ID: 31570854
[TBL] [Abstract][Full Text] [Related]
6. FAM134B induces tumorigenesis and epithelial-to-mesenchymal transition via Akt signaling in hepatocellular carcinoma.
Zhang ZQ; Chen J; Huang WQ; Ning D; Liu QM; Wang C; Zhang L; Ren L; Chu L; Liang HF; Fan HN; Zhang BX; Chen XP
Mol Oncol; 2019 Apr; 13(4):792-810. PubMed ID: 30556279
[TBL] [Abstract][Full Text] [Related]
7. NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner.
Li H; Lan T; Xu L; Liu H; Wang J; Li J; Chen X; Huang J; Li X; Yuan K; Zeng Y; Wu H
J Exp Clin Cancer Res; 2020 Jul; 39(1):128. PubMed ID: 32631394
[TBL] [Abstract][Full Text] [Related]
8. KIAA1217 Promotes Epithelial-Mesenchymal Transition and Hepatocellular Carcinoma Metastasis by Interacting with and Activating STAT3.
Wang Y; Li N; Zheng Y; Wang A; Yu C; Song Z; Wang S; Sun Y; Zheng L; Wang G; Liu L; Yi J; Huang Y; Zhang M; Bao Y; Sun L
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008530
[TBL] [Abstract][Full Text] [Related]
9. Deregulated AJAP1/β-catenin/ZEB1 signaling promotes hepatocellular carcinoma carcinogenesis and metastasis.
Han J; Xie C; Pei T; Wang J; Lan Y; Huang K; Cui Y; Wang F; Zhang J; Pan S; Liang Y; Zhen T; Song R; Sun B; Li Y; Shi H; Yang G; Liu X; Zhu M; Wang Y; Li K; Liu Y; Meng F; Liao F; Meng X; Hong X; Liu L
Cell Death Dis; 2017 Apr; 8(4):e2736. PubMed ID: 28383563
[TBL] [Abstract][Full Text] [Related]
10. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of SNHG6 regulates ZEB1 expression by competitively binding miR-101-3p and interacting with UPF1 in hepatocellular carcinoma.
Chang L; Yuan Y; Li C; Guo T; Qi H; Xiao Y; Dong X; Liu Z; Liu Q
Cancer Lett; 2016 Dec; 383(2):183-194. PubMed ID: 27702662
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma.
Song M; Pan Q; Yang J; He J; Zeng J; Cheng S; Huang Y; Zhou ZQ; Zhu Q; Yang C; Han Y; Tang Y; Chen H; Weng DS; Xia JC
Br J Cancer; 2020 Nov; 123(10):1521-1534. PubMed ID: 32801345
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
[TBL] [Abstract][Full Text] [Related]
14. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
[TBL] [Abstract][Full Text] [Related]
15. Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression.
Dong Y; Sun X; Zhang K; He X; Zhang Q; Song H; Xu M; Lu H; Ren R
Bioengineered; 2021 Dec; 12(2):12967-12979. PubMed ID: 34939898
[TBL] [Abstract][Full Text] [Related]
16. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
Jin Y; Wang J; Han J; Luo D; Sun Z
Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
[TBL] [Abstract][Full Text] [Related]
17. Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition.
Xiao S; Chang RM; Yang MY; Lei X; Liu X; Gao WB; Xiao JL; Yang LY
Hepatology; 2016 Apr; 63(4):1256-71. PubMed ID: 26698646
[TBL] [Abstract][Full Text] [Related]
18. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
[TBL] [Abstract][Full Text] [Related]
19. Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.
Zhu K; Dai Z; Pan Q; Wang Z; Yang GH; Yu L; Ding ZB; Shi GM; Ke AW; Yang XR; Tao ZH; Zhao YM; Qin Y; Zeng HY; Tang ZY; Fan J; Zhou J
Clin Cancer Res; 2011 Dec; 17(23):7294-302. PubMed ID: 21976539
[TBL] [Abstract][Full Text] [Related]
20. Programmed cell death 10 promotes metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma via PP2Ac-mediated YAP activation.
Sun B; Zhong FJ; Xu C; Li YM; Zhao YR; Cao MM; Yang LY
Cell Death Dis; 2021 Sep; 12(9):849. PubMed ID: 34521817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]